{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:14:04Z","timestamp":1791335644283,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FABR2017"],"award-info":[{"award-number":["FABR2017"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBFR12SOQ1"],"award-info":[{"award-number":["RBFR12SOQ1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007385","name":"Fondazione Cassa di Risparmio in Bologna","doi-asserted-by":"publisher","award":["Transcan-2-JTC 2017"],"award-info":[{"award-number":["Transcan-2-JTC 2017"]}],"id":[{"id":"10.13039\/100007385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2011-02348356"],"award-info":[{"award-number":["GR-2011-02348356"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008877","name":"Biosensors International Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG21408"],"award-info":[{"award-number":["IG21408"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jtho.2019.03.029","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:26:28Z","timestamp":1557401188000},"page":"1458-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"14","author":[{"given":"Iris C.","family":"Salaroglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kopecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Pradotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Costardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gagliasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladan","family":"Milosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeta","family":"Ananthanarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bironzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tabb\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta F.","family":"Cartia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Passone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Comunanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ardissone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ruffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bussolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio V.","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2019.03.029_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","article-title":"Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies","volume":"41","author":"Remon","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtho.2019.03.029_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/annonc\/mdv101","article-title":"Searching for\u00a0targets for the systemic therapy of mesothelioma","volume":"26","author":"Stahel","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/2326-6066.CIR-16-0171","article-title":"Cytotoxic T cells in PD-L1\u2013positive malignant pleural mesotheliomas are counterbalanced by distinct immunosuppressive factors","volume":"4","author":"Awad","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jtho.2019.03.029_bib4","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-17-3757","article-title":"Tumor-derived GM-CSF promotes granulocyte immunosuppression in mesothelioma patients","volume":"24","author":"Khanna","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2019.03.029_bib5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ctrv.2015.09.006","article-title":"Targeting immune checkpoints: new opportunity for mesothelioma treatment?","volume":"41","author":"Marcq","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtho.2019.03.029_bib6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1183\/09031936.06.00135305","article-title":"Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses","volume":"27","author":"Hegmans","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtho.2019.03.029_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.18632\/oncotarget.2731","article-title":"Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma","volume":"6","author":"Salaroglio","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2019.03.029_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106742","article-title":"Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma","volume":"9","author":"Cornelissen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2019.03.029_bib9","first-page":"34","article-title":"Immunotherapy prospects in the treatment of lung cancer and mesothelioma","volume":"3","author":"Aerts","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2019.03.029_bib10","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jtho.2016.06.021","article-title":"Pleural effusion of patients with malignant mesothelioma induces macrophage-mediated T cell suppression","volume":"11","author":"Lievense","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jtho.2016.06.022","article-title":"Pleural effusions from patients with mesothelioma induce recruitment of monocytes and their differentiation into M2 macrophages","volume":"11","author":"Ch\u00e9n\u00e9","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1173299","article-title":"Murine mesothelioma induces locally-proliferating IL-10(+)TNF-\u03b1(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy","volume":"5","author":"Jackaman","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtho.2019.03.029_bib13","article-title":"Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment","volume":"7","author":"Riganti","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtho.2019.03.029_bib14","article-title":"Phenotype, development, and biological function of myeloid-derived suppressor cells","volume":"5","author":"Zhao","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtho.2019.03.029_bib15","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1158\/0008-5472.CAN-14-0473","article-title":"Vaccine-elicited CD8+ T cells cure mesothelioma by overcoming tumor-induced immunosuppressive environment","volume":"74","author":"Tan","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2019.03.029_bib16","doi-asserted-by":"crossref","first-page":"32426","DOI":"10.18632\/oncotarget.5856","article-title":"Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2019.03.029_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1009285","article-title":"The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: a comprehensive analysis reveals prognostic immune markers","volume":"4","author":"Ujiie","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtho.2019.03.029_bib18","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1186\/1471-2407-13-324","article-title":"Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid","volume":"13","author":"Scherpereel","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtho.2019.03.029_bib19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jtho.2016.07.033","article-title":"Malignant mesothelioma effusions are infiltrated by CD3(+) T cells highly expressing PD-L1 and the PD-L1(+) tumor cells within these effusions are susceptible to ADCC by the anti\u2013PD-L1 antibody avelumab","volume":"11","author":"Khanna","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","article-title":"Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time","volume":"29","author":"Pasello","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtho.2017.09.1968","article-title":"Molecular and histopathological characterization of the tumor immune microenvironment in advanced stage of malignant pleural mesothelioma","volume":"13","author":"Patil","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121071","article-title":"Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)","volume":"10","author":"Cedr\u00e9s","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2019.03.029_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2016.01.010","article-title":"Immune biomarkers PD-1\/PD-L1 and TLR3 in malignant pleural mesotheliomas","volume":"52","author":"Combaz-Lair","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2019.03.029_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/srep31745","article-title":"Fine needle aspirate\u00a0flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironment","volume":"6","author":"Lizotte","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2019.03.029_bib25","article-title":"Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma","volume":"6","author":"Marcq","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtho.2019.03.029_bib26","doi-asserted-by":"crossref","first-page":"89722","DOI":"10.18632\/oncotarget.21113","article-title":"Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients","volume":"8","author":"Marcq","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2019.03.029_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(17)30446-1","article-title":"Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial","volume":"18","author":"Maio","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lungcan.2016.04.015","article-title":"Precision immunotherapy; dynamics in the cellular profile of pleural effusions\u00a0in malignant mesothelioma patients","volume":"107","author":"Lievense","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2019.03.029_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041041","article-title":"Heterogeneity in immune cell content in malignant pleural mesothelioma","volume":"19","author":"Minnema-Luiting","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"suppl 5","key":"10.1016\/j.jtho.2019.03.029_bib30","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for\u00a0diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2019.03.029_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2015.02.008","article-title":"Two repeated low doses of doxorubicin are more effective than a single high dose against tumors overexpressing P-glycoprotein","volume":"360","author":"Riganti","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtho.2019.03.029_bib32","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1186\/1476-4598-8-108","article-title":"iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells","volume":"8","author":"De Boo","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jtho.2019.03.029_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126159","article-title":"An autocrine cytokine\/JAK\/STAT-signaling induces kynurenine synthesis in multidrug resistant human cancer cells","volume":"10","author":"Campia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2019.03.029_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.lungcan.2015.03.013","article-title":"Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma","volume":"88","author":"Cornelissen","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2019.03.029_bib35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00262-017-1979-x","article-title":"The PD-L1\/PD-1 pathway promotes dysfunction, but not \u201cexhaustion,\u201d in tumor-responding T cells from pleural effusions in lung cancer patients","volume":"66","author":"Prado-Garcia","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jtho.2019.03.029_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2008.02.011","article-title":"CTLA-4 trafficking and\u00a0surface expression","volume":"29","author":"Valk","year":"2008","journal-title":"Trends Immunol"}],"updated-by":[{"DOI":"10.1016\/j.jtho.2019.09.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000}}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086419303570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086419303570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:27:32Z","timestamp":1778819252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086419303570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1556086419303570"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2019.03.029","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2019.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}